Articoli correlati
vaccini a base di frammenti proteici
Candidate cancer vaccines based on protein fragments, representing about 40% of the early-phase trials described.
Articoli correlati
Candidate cancer vaccines based on protein fragments, representing about 40% of the early-phase trials described.